Liver Transplantation for Hepatocellular Carcinoma
- 5 March 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Gastroenterology Reports
- Vol. 17 (3)
- https://doi.org/10.1007/s11894-015-0435-3
Abstract
Hepatocellular carcinoma (HCC) is an increasing problem in the USA and worldwide. Current treatments for HCC include chemoembolization, radioembolization, liver resection, and liver transplantation in the setting of selected cirrhotic patients. Liver transplantation for HCC was controversial initially, but is now widely accepted as a curative approach. Cirrhotic patients who meet standards for transplantation and have a tumor burden within Milan criteria are eligible for transplantation and receive Model for End-Stage Liver Disease (MELD) exception points once listed. Given the decline in availability of donor organs, rewarding MELD exception points and performing liver transplants in these patients remain controversial. Despite this, various guidelines propose expanding eligibility criteria for cirrhotics with HCC, due to post-transplant outcomes comparable to patients transplanted without HCC. Following the transplant, issues include optimizing the type and amount of immunosuppression and screening for and treating recurrence of HCC.Keywords
This publication has 34 references indexed in Scilit:
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2011
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival TimesGastroenterology, 2011
- Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer CellsCancer Research, 2009
- Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2008
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progressionTransplantation, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003
- A model to predict survival in patients with end-stage liver diseaseJournal of Hepatology, 2001